Nevirapine 200 mg
Nevirapine 200 mg Tablets belong to the non-nucleoside reverse transcriptase inhibitor (NNRTI) class and are used in combination antiretroviral regimens for the management of HIV-1 infection, following nationally and internationally accepted treatment guidance.
Product Details
Therapeutic Class
Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
200 mg administered as per recommended dosing schedules, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
60 tablets
Nevirapine 200 mg
Nevirapine 200 mg Tablets belong to the non-nucleoside reverse transcriptase inhibitor (NNRTI) class and are used in combination antiretroviral regimens for the management of HIV-1 infection, following nationally and internationally accepted treatment guidance.
Product Details
Therapeutic Class
Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
200 mg administered as per recommended dosing schedules, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
60 tablets
Nevirapine 200 mg
Nevirapine 200 mg Tablets belong to the non-nucleoside reverse transcriptase inhibitor (NNRTI) class and are used in combination antiretroviral regimens for the management of HIV-1 infection, following nationally and internationally accepted treatment guidance.
Product Details
Therapeutic Class
Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
200 mg administered as per recommended dosing schedules, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
60 tablets